相关实验视频

Updated: Jan 7, 2026

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Published on: September 18, 2020

CD14^- CD16⁺单细胞PD-L1可以防止结核病的早期进展,并限制免疫检查点治疗下的重新激活

Wentao Wang^1,2, Chenyang Liu^1,2, Wenxaio Wu^1,2

¹School of Laboratory Medicine, Shandong Second Medical University, Weifang, China.

Frontiers in cellular and infection microbiology

|December 25, 2025

概括

针对PD-L1的免疫检查点封锁可以通过降低PD-L1对特定单细胞的调节来增加结核病 (TB) 风险. 在这些单细胞上抑制PD-L1可能会防止结核病的重新激活,特别是在免疫受损的个体中.

科学领域:

免疫学和传染病的研究
在瘤免疫学上.
药理学药理学是指药理学的学科.

背景情况:

免疫检查点封锁 (ICB) 已经改变了癌症治疗,但它对结核病 (TB) 等慢性感染的影响尚未完全理解.
单细胞上的PD-L1表达在免疫调节中起作用,但其在结核病发病过程中的具体功能尚不清楚.

研究的目的:

研究PD-L1表达在CD14-CD16+单细胞在预防早期结核病进展中的作用.
确定PD-L1下调和增加结核病风险之间的因果关系,特别是在ICB治疗的背景下.

主要方法:

对现实世界不良事件数据 (FAERS数据库) 的分析,以寻找PD-L1抑制剂和结核病之间的关联.
门德尔随机化 (MR) 用于评估基因决定的PD-L1表达对结核病风险的因果关系.
单细胞的转录形状分析,以了解PD-L1表达水平的功能后果.
在 silico 药物预测和分子对接,然后在体外验证潜在的治疗化合物.

主要成果:

PD-L1抑制剂杜尔瓦卢马布与结核病相关的不良事件有显著的关联.
在CD14-CD16+单细胞中PD-L1表达的升高与预防早期结核病进展有因果关系.
PD-L1高单细胞显示增强了抗原监测,而PD-L1低单细胞显示了与免疫逃逸相关的代谢变化.
利科林被确定为一种可以调节PD-L1并抑制Mycobacterium结核病活性化的化合物.

结论:

在CD14-CD16+单细胞上的PD-L1表达是控制早期结核病的关键机制.
阻断PD-L1可能会增加结核病再激活的风险,强调需要仔细监测患者.
针对单细胞中的PD-L1调节,为预防脆弱人群的结核病再激活提供了一个潜在的策略.

关键词:

在CD14-CD16+单细胞中.在PD-L1中.免疫检查点是一个检查点.潜伏的结核病感染.转录规则转录规则转录规则

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...